Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
PheWu1y9PSdqq5eb
